Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
AI

Anthony Ingall — 18 Patents

Astrazeneca Ab: 8 patents #153 of 1,971Top 8%
ALAstra Pharmaceuticals Limited.: 4 patents #7 of 36Top 20%
ALAstrazeneca Uk Limited: 3 patents #28 of 159Top 20%
FPFisons Plc: 3 patents #25 of 140Top 20%
Minehead, GB: #1 of 5 inventorsTop 20%
Overall (All Time): #245,716 of 4,157,543Top 6%
18 Patents All Time
Anthony Ingall has been granted 18 US patents while listed as an inventor at Astrazeneca Ab. The first was granted in 1980 and the most recent in January 2017. Anthony Ingall ranks #245,716 of 4,157,543 US inventors in our database (top 5.9%). Patent records list Anthony Ingall in Minehead, GB.

Issued Patents All Time

Showing 1–18 of 18 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
RE46276 Triazolo(4,5-D)pyrimidine compounds David Hardem, Brian Springthorpe, Paul Willis, Simon Guile 2017-01-17
7393854 Thienopyrimidinedinones and their use in modulation of autoimmune disease Simon Guile 2008-07-01 $20,646,000
7384950 Thienopyrimidinediones and their use in the modulation of autoimmune disease Rachel Heulwen Reynolds, Rukhsana Rasul, Simon Guile, Martin Cooper 2008-06-10 $5,253,000
7361660 Chemical compounds Rachel Heulwen Reynolds 2008-04-22 $32,861,000
7250419 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition David Hardern, Brian Springthorpe, Paul Willis, Simon Guile 2007-07-31 $36,849,000
7064126 Compounds Martin Cooper, Simon Guile, Rukhsana Rasul 2006-06-20 $10,429,000
6974868 Compounds David Hardern, Brian Springthorpe, Paul Willis, Simon Guile 2005-12-13 $11,892,000
6890923 Compounds John Bantick, Matthew Perry 2005-05-10 $33,636,000
6525060 Triazolo(4,5-d)pyrimidine compounds David Hardern, Brian Springthorpe, Paul Willis, Simon Guile 2003-02-25 $5,431,000
6297232 Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments Roger Bonnert, Brian Springthorpe, Paul Willis 2001-10-02 $30,815,000
6251910 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists Simon Guile, Brian Springthorpe, Paul Willis 2001-06-26 $10,685,000
5955447 N-alkyl-2-substituted ATP analogues for treatment of embolic disease conditions Peter Cage, Nicholas Kindon 1999-09-21
5747496 Inhibitors of platelet aggregation David Cox, Paul Willis 1998-05-05
5721219 N-alkyl-2-substituted ATP analogues and administration to inhibit platelet aggregation Peter Cage, Nicholas Kindon 1998-02-24
5654285 ADP and ATP analogues, process for making and administration to inhibit ADP-induced platelet aggregation Peter Cage 1997-08-05
4900751 2-Pyridinyl-phenyl-sulphinyl-and-phenyl-thio-benzimidazoles having antiflammatory or gastic acid secretion inhibition activity David Cox, Hossein A. Dowlatshahi, David E. Hall, John L. Suschitzky 1990-02-13 $93,000
4851419 Certain 2-pyridinyl-phenylsulfinyl-benzoxazoles, the corresponding benzothiazoles or benzimidazoles having anti-inflammatory or gastric acid secretion inhibition activity David Cox, David E. Hall, John L. Suschitzky 1989-07-25 $214,000
4228173 Thiopyrano-benzopyrans, compositions and method of use thereof Hugh Cairns 1980-10-14 $710,000